Johnson & Johnson (NYSE:JNJ) is a healthcare company engaged in the research, development, manufacturing, and marketing of a ...

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are ...

We recently caught up with Nick Karls, director of compliance at Holmes Murphy and Associates, and Nathan Cassin, pharmacy ...

Johnson & Johnson is considering selling its stroke care unit, Cerenovus, in a potential $1 billion deal as part of its ...

Johnson & Johnson aims to streamline operations by selling its stroke care business, Cerenovus, valued at $1B+.

In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other Kevin O’Leary’s stock picks for 2025. Television personality, financier, and ...

WASHINGTON — Speaker Mike Johnson, R-La., has informed Rep. Mike Turner, R-Ohio, that he will no longer be chairman of the House Intelligence Committee, according to a GOP leadership source and ...

Four members of the Chicago Bears' brass were calling to tell the 2024 first overall draft pick news he wanted to hear: They were hiring Detroit Lions offensive coordinator Ben Johnson.

Good morning and welcome to Johnson & Johnson's Fourth Quarter 2024 ... immunology and neuroscience in Innovative Medicine and cardiovascular, vision and robotics in MedTech.

Good morning and welcome to Johnson & Johnson's fourth quarter 2024 earnings conference call. All participants will be in a listen-only mode until the question-and-answer session of the conference.

"Our entire organization is fired up about Ben Johnson," Poles said. "Throughout the entire process, we came away really impressed with his passion, his leadership, his football IQ and his vision for ...

Mario Tama / Getty Images Johnson & Johnson's fourth quarter sales met estimates, while net income fell short. After adjusting for one-time costs like acquisitions, the drug and medical device ...